Stay updated with breaking news from Adxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research report released on Monday. The firm issued a sell rating on the biotechnology company’s stock. Ayala Pharmaceuticals Price Performance Shares of OTCMKTS:ADXS opened at $1.50 on Monday. The firm has a market capitalization of $2.72 million, a PE ratio of […]
Investment analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research report issued on Friday. The brokerage set a “sell” rating on the stock. Ayala Pharmaceuticals Trading Down 10.0 % Ayala Pharmaceuticals stock traded down $0.15 during midday trading on Friday, hitting $1.35. The company’s stock had a […]
Investment analysts at StockNews.com initiated coverage on shares of Advaxis (NASDAQ:ADXS – Get Rating) in a research note issued on Monday. The firm set a “sell” rating on the stock. Advaxis Price Performance About Advaxis (Get Rating) Advaxis, Inc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) […]
Advaxis (OTCMKTS: ADXS) has recently received a number of price target changes and ratings updates: 4/11/2022 – Advaxis is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/5/2022 – Advaxis is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 4/4/2022 – Advaxis is […]
StockNews.com assumed coverage on shares of Advaxis (OTCMKTS:ADXS – Get Rating) in a report issued on Monday. The firm set a “sell” rating on the biotechnology company’s stock. Shares of ADXS opened at $0.10 on Monday. Advaxis has a one year low of $0.08 and a one year high of $0.76. The company has a […]